Study to Evaluate Impact SANKOM Patent Socks in Patients With CVI
Open Label, Prospective Clinical Trial to Evaluate Impact on Quality of Life in Chronic Venous Insufficiency Patients Using SANKOM® Patent Socks During 4 Weeks
1 other identifier
interventional
30
1 country
2
Brief Summary
Clinical study to evaluate impact on quality of life in patients with Chronic Venous Insufficiency during 4 weeks period of using SANKOM® Patent Socks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2018
CompletedFirst Submitted
Initial submission to the registry
February 14, 2018
CompletedFirst Posted
Study publicly available on registry
February 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedMarch 2, 2018
February 1, 2018
2 months
February 14, 2018
February 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of health status in varicose veins patients
By mean of growing Aberdeen Varicose Veins Questionnaire score (total range 0 - 60). The higher values represent a better outcome.
4 weeks
Secondary Outcomes (3)
Improvement of Quality of Life
4 weeks
Improvement of ultara sound examination measures
4 weeks
Improvement of subject's self-assessment questionnaire
4 weeks
Study Arms (1)
Patients using investigational product
EXPERIMENTALOpen-label use of SANKOM Patent Socks
Interventions
Using compression socks to ease symptoms of patients with chronic venous insufficiency
Eligibility Criteria
You may qualify if:
- Subject is informed and given ample time and opportunity to think about his/her participation and has given his/her written informed consent before any procedure;
- Subject is male or female, 35-65 years of age;
- Subject with chronic venous insufficiency CEAP (C1, C2);
- Subject can speak and understand Ukrainian or Russian language.
You may not qualify if:
- Subject participated in any clinical study (drug or device) within 6 months prior to the screening;
- Subject unable to wear compression stockings;
- Subject using other compression therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sankom SAlead
- InterMedService SAcollaborator
- Pharmaxi LLCcollaborator
Study Sites (2)
Kyiv City Clinical Hospital No 6
Kyiv, 03126, Ukraine
Medical Consulting Center of Pechersk District
Kyiv, Ukraine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Serge M Mazourik, MD
Intermedservice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2018
First Posted
February 26, 2018
Study Start
February 5, 2018
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
March 2, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share the data yet.